fda semaglutide warning november 2025 Novo Nordisk Seeks Approval For Higher Dose of Wegovy Weight-Loss Shot fda warning glp-1 november 2025

[20] Specifically, the medication may enhance production of annexin-1, which could contribute to anti-inflammatory effects through inhibition of phospholipase A2 activity

Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE-TIMI 58 randomised trial

Weve also seen data that semaglutide has been shown to have anti-inflammatory and cardiovascular benefits, which can further protect the kidneys from damage. If the heart pumps better, Whyte added, the kidney is going to function better. The role of GLP-1 medications for treating obesity is just one of several surprising findings uncovered since their introduction to the market

Its job is to help your body adjust to semaglutide and reduce the risk of gastrointestinal side effects

Does Ozempic cause deep vein thrombosis (DVT)

With four additional Novo Nordisk patents still under challenge, this ruling has sparked widespread discussion among biotech investors, generic drug manufacturers, and healthcare professionals